Integrity Alliance’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.55M Sell
7,924
-53
-0.7% -$10.3K 0.06% 237
2025
Q4
$1.38M Sell
7,977
-804
-9% -$146K 0.05% 266
2025
Q3
$1.67M Buy
8,781
+3,287
+60% +$583K 0.08% 189
2025
Q2
$987K Sell
5,494
-8,294
-60% -$1.44M 0.05% 221
2025
Q1
$2.33M Buy
13,788
+4,716
+52% +$775K 0.09% 170
2024
Q4
$1.37M Buy
+9,072
New +$1.41M 0.15% 86

Other funds holding DGX

Integrity Alliance's DGX Position: Q1 2026 in Review

Integrity Alliance reduced its Quest Diagnostics (DGX) stake by 0.66% in Q1 2026, selling an estimated $10.3K and leaving 7,924 shares worth $1.55M. The position accounts for 0.06% of the portfolio, ranked #237.

Integrity Alliance first reported a position in DGX in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.33M in Q1 2025. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Integrity Alliance held 7,924 shares of Quest Diagnostics worth $1.55M as of Q1 2026.
  • Integrity Alliance sold 53 Quest Diagnostics shares in Q1 2026, an estimated $10.3K.
  • Quest Diagnostics made up 0.06% of Integrity Alliance's portfolio in Q1 2026, its #237 holding.
  • Integrity Alliance first reported a position in Quest Diagnostics in Q4 2024 and has held it in 6 quarters since.
  • Integrity Alliance's Quest Diagnostics position peaked at $2.33M in Q1 2025.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Integrity Alliance's 13F filing for Q1 2026, filed 11 May 2026.